Authors:
Liu, L
Li, H
Underwood, T
Lloyd, M
David, M
Sperl, G
Pamukcu, R
Thompson, WJ
Citation: L. Liu et al., Cyclic GMP-dependent protein kinase activation and induction by exisulind and CP461 in colon tumor cells, J PHARM EXP, 299(2), 2001, pp. 583-592
Authors:
Thompson, WJ
Piazza, GA
Li, H
Liu, L
Fetter, J
Zhu, B
Sperl, G
Ahnen, D
Pamukcu, R
Citation: Wj. Thompson et al., Exisulind induction of apoptosis involves guanosine 3 ',5 '-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated beta-catenin, CANCER RES, 60(13), 2000, pp. 3338-3342
Authors:
Sperl, GJ
Pamukcu, R
Brendel, K
Gross, PH
Citation: Gj. Sperl et al., Synthesis of radioactive sulindac-sulfone-lactone via sulfonium salt and C-14 alkylhalide, J LABEL C R, 42(9), 1999, pp. 877-883
Authors:
Goluboff, ET
Shabsigh, A
Saidi, JA
Weinstein, IB
Mitra, N
Heitjan, D
Piazza, GA
Pamukcu, R
Buttyan, R
Olsson, CA
Citation: Et. Goluboff et al., Exsulind (sulindac sulfone) suppresses growth of human prostate cancer in a nude mouse xenograft model by increasing apoptosis, UROLOGY, 53(2), 1999, pp. 440-445
Authors:
Lim, JTE
Piazza, GA
Han, EKH
Delohery, TM
Li, H
Finn, TS
Buttyan, R
Yamamoto, H
Sperl, GJ
Brendel, K
Gross, PH
Pamukcu, R
Weinstein, IB
Citation: Jte. Lim et al., Sulindac derivatives inhibit growth and induce apoptosis in human prostatecancer cell lines, BIOCH PHARM, 58(7), 1999, pp. 1097-1107
Authors:
Skopinska-Rozewska, E
Piazza, GA
Sommer, E
Pamukcu, R
Barcz, E
Filewska, M
Kupis, W
Caban, R
Rudzinski, P
Bogdan, J
Mlekodaj, S
Sikorska, E
Citation: E. Skopinska-rozewska et al., Inhibition of angiogenesis by sulindac and its sulfone metabolite (FGN-1):A potential mechanism for their antineoplastic properties, INT J TISS, 20(3), 1998, pp. 85-89